Erytropoietin behandling kan forbedre kognition ved neuropsykiatriske lidelser

Kristian Skov Kjær; Ida Hageman; Gitta Wörtwein; Martin Balslev Jørgensen; Kamilla Woznica Miskowiak

Erytropoietin behandling kan forbedre kognition ved neuropsykiatriske lidelser

Kristian Skov Kjær, Ida Hageman, Gitta Wörtwein, Martin Balslev Jørgensen, Kamilla Woznica Miskowiak

1 Citationer (Scopus)

Abstract

Cognitive dysfunction is a core feature in a range of neuropsychiatric disorders which reduces patients' workforce capacity - the largest socio-economic cost of these disorders. Nevertheless, there is no clinically available medical treatment with robust and enduring efficacy on cognitive deficits in most neuropsychiatric conditions. Recent research has shown that erythropoietin may have beneficial effects on cognitive dysfunction across neuropsychiatric disorders, including bipolar and unipolar disorders, schizophrenia, Parkinson's disease and multiple sclerosis.

Bidragets oversatte titel	Erythropoietin treatment may improve cognition in neuropsychiatric disorders
Originalsprog	Dansk
Artikelnummer	V01170037
Tidsskrift	Ugeskrift for Laeger
Vol/bind	179
Udgave nummer	22
Sider (fra-til)	2-6
Antal sider	5
ISSN	0041-5782
Status	Udgivet - 14 aug. 2017

Adgang til dokumentet

http://ugeskriftet.dk/videnskab/erytropoietinbehandling-kan-forbedre-kognition-ved-neuropsykiatriske-lidelser

Citationsformater

@article{2b26f6d8d6dd44799b9bc88d0c57d3c0,

title = "Erytropoietin behandling kan forbedre kognition ved neuropsykiatriske lidelser",

abstract = "Cognitive dysfunction is a core feature in a range of neuropsychiatric disorders which reduces patients' workforce capacity - the largest socio-economic cost of these disorders. Nevertheless, there is no clinically available medical treatment with robust and enduring efficacy on cognitive deficits in most neuropsychiatric conditions. Recent research has shown that erythropoietin may have beneficial effects on cognitive dysfunction across neuropsychiatric disorders, including bipolar and unipolar disorders, schizophrenia, Parkinson's disease and multiple sclerosis.",

keywords = "English Abstract, Journal Article",

author = "Kj{\ae}r, {Kristian Skov} and Ida Hageman and Gitta W{\"o}rtwein and J{\o}rgensen, {Martin Balslev} and Miskowiak, {Kamilla Woznica}",

year = "2017",

month = aug,

day = "14",

language = "Dansk",

volume = "179",

pages = "2--6",

journal = "Ugeskrift for Laeger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "22",

}

TY - JOUR

T1 - Erytropoietin behandling kan forbedre kognition ved neuropsykiatriske lidelser

AU - Kjær, Kristian Skov

AU - Hageman, Ida

AU - Wörtwein, Gitta

AU - Jørgensen, Martin Balslev

AU - Miskowiak, Kamilla Woznica

PY - 2017/8/14

Y1 - 2017/8/14

N2 - Cognitive dysfunction is a core feature in a range of neuropsychiatric disorders which reduces patients' workforce capacity - the largest socio-economic cost of these disorders. Nevertheless, there is no clinically available medical treatment with robust and enduring efficacy on cognitive deficits in most neuropsychiatric conditions. Recent research has shown that erythropoietin may have beneficial effects on cognitive dysfunction across neuropsychiatric disorders, including bipolar and unipolar disorders, schizophrenia, Parkinson's disease and multiple sclerosis.

AB - Cognitive dysfunction is a core feature in a range of neuropsychiatric disorders which reduces patients' workforce capacity - the largest socio-economic cost of these disorders. Nevertheless, there is no clinically available medical treatment with robust and enduring efficacy on cognitive deficits in most neuropsychiatric conditions. Recent research has shown that erythropoietin may have beneficial effects on cognitive dysfunction across neuropsychiatric disorders, including bipolar and unipolar disorders, schizophrenia, Parkinson's disease and multiple sclerosis.

KW - English Abstract

KW - Journal Article

M3 - Tidsskriftartikel

C2 - 28869012

SN - 0041-5782

VL - 179

SP - 2

EP - 6

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

IS - 22

M1 - V01170037

ER -

Erytropoietin behandling kan forbedre kognition ved neuropsykiatriske lidelser

Abstract

Adgang til dokumentet

Fingeraftryk

Citationsformater